Skip to main content
Top
Published in: Diabetologia 9/2016

01-09-2016 | Article

The association of ideal cardiovascular health with incident type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis

Authors: Joshua J. Joseph, Justin B. Echouffo-Tcheugui, Mercedes R. Carnethon, Alain G. Bertoni, Christina M. Shay, Haitham M. Ahmed, Roger S. Blumenthal, Mary Cushman, Sherita H. Golden

Published in: Diabetologia | Issue 9/2016

Login to get access

Abstract

Aims/hypothesis

Levels of ideal cardiovascular health (ICH) and incident type 2 diabetes mellitus have not been examined in a multiethnic population. We assessed the total and race/ethnicity-specific incidence of diabetes based on American Heart Association (AHA) ICH components.

Methods

Incident diabetes was assessed among 5341 participants in the Multi-Ethnic Study of Atherosclerosis without prevalent diabetes between 2002 and 2012. ICH components (total cholesterol, BP, dietary intake, tobacco use, physical activity and BMI) were assessed at baseline and participants were categorised as having ideal, intermediate or poor cardiovascular health, as defined by the AHA 2020 impact goals. We developed a scoring system based on the number of ICH components (0–1 ‘poor’, 2–3 ‘intermediate’, and ≥4 ‘ideal’). HRs were calculated using Cox models.

Results

During a median follow-up of 11.1 years, we identified 587 cases of incident diabetes. After multivariable adjustment, participants with 2–3 and ≥4 ICH components vs 0–1 components had a 34% lower (HR 0.66; 95% CI 0.54, 0.80) and a 75% lower (HR 0.25; 95% CI 0.18, 0.35) diabetes incidence, respectively. There were significant differences by race/ethnicity: African-American and Hispanic-American participants with ≥4 ICH components had diabetes incidence rates per 1000 person-years of 5.6 (95% CI 3.1, 10.1) and 10.5 (95% CI 6.7, 16.4), respectively, compared with 2.2 (95% CI 1.3, 3.7) among non-Hispanic white Americans.

Conclusions/interpretation

Meeting an increasing number of AHA 2020 impact goals for dietary intake, physical activity, smoking, BP, cholesterol and BMI was associated with a dose-dependent lower risk of diabetes with significant variation by race/ethnicity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lloyd-Jones DM, Hong Y, Labarthe D et al (2010) Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation 121:586–613CrossRefPubMed Lloyd-Jones DM, Hong Y, Labarthe D et al (2010) Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation 121:586–613CrossRefPubMed
2.
go back to reference Gress TW, Nieto FJ, Shahar E et al (2000) Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med 342:905–912CrossRefPubMed Gress TW, Nieto FJ, Shahar E et al (2000) Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med 342:905–912CrossRefPubMed
3.
go back to reference Taylor KS, Heneghan CJ, Farmer AJ et al (2013) All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care 36:2366–2371CrossRefPubMedPubMedCentral Taylor KS, Heneghan CJ, Farmer AJ et al (2013) All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care 36:2366–2371CrossRefPubMedPubMedCentral
4.
go back to reference Kulshreshtha A, Vaccarino V, Judd SE et al (2013) Life’s simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke 44:1909–1914CrossRefPubMed Kulshreshtha A, Vaccarino V, Judd SE et al (2013) Life’s simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke 44:1909–1914CrossRefPubMed
5.
go back to reference Folsom AR, Yatsuya H, Nettleton JA et al (2011) Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol 57:1690–1696CrossRefPubMedPubMedCentral Folsom AR, Yatsuya H, Nettleton JA et al (2011) Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol 57:1690–1696CrossRefPubMedPubMedCentral
6.
go back to reference Fretts AM, Howard BV, McKnight B et al (2014) Life’s simple 7 and incidence of diabetes among American Indians: the Strong Heart Family Study. Diabetes Care 37:2240–2245CrossRefPubMedPubMedCentral Fretts AM, Howard BV, McKnight B et al (2014) Life’s simple 7 and incidence of diabetes among American Indians: the Strong Heart Family Study. Diabetes Care 37:2240–2245CrossRefPubMedPubMedCentral
7.
go back to reference Bild DE (2002) Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 156:871–881CrossRefPubMed Bild DE (2002) Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 156:871–881CrossRefPubMed
8.
go back to reference Bertoni AG, Whitt-Glover MC, Chung H et al (2008) The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 169:444–454CrossRefPubMedPubMedCentral Bertoni AG, Whitt-Glover MC, Chung H et al (2008) The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 169:444–454CrossRefPubMedPubMedCentral
9.
go back to reference Cushman M, Cornell ES, Howard PR et al (1995) Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41:264–270PubMed Cushman M, Cornell ES, Howard PR et al (1995) Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41:264–270PubMed
11.
12.
go back to reference Mozaffarian D, Kamineni A, Carnethon M et al (2009) Lifestyle risk factors and new-onset diabetes mellitus in older adults: the Cardiovascular Health Study. Arch Intern Med 169:798–807CrossRefPubMedPubMedCentral Mozaffarian D, Kamineni A, Carnethon M et al (2009) Lifestyle risk factors and new-onset diabetes mellitus in older adults: the Cardiovascular Health Study. Arch Intern Med 169:798–807CrossRefPubMedPubMedCentral
13.
go back to reference Reis JP, Loria CM, Sorlie PD et al (2011) Lifestyle factors and risk for new-onset diabetes: a population-based cohort study. Ann Intern Med 155:292–299CrossRefPubMedPubMedCentral Reis JP, Loria CM, Sorlie PD et al (2011) Lifestyle factors and risk for new-onset diabetes: a population-based cohort study. Ann Intern Med 155:292–299CrossRefPubMedPubMedCentral
14.
go back to reference Geiss LS, Wang J, Cheng YJ et al (2014) Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA 312:1218CrossRefPubMed Geiss LS, Wang J, Cheng YJ et al (2014) Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA 312:1218CrossRefPubMed
15.
go back to reference Shay CM, Ning H, Allen NB et al (2012) Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003–2008. Circulation 125:45–56CrossRefPubMed Shay CM, Ning H, Allen NB et al (2012) Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003–2008. Circulation 125:45–56CrossRefPubMed
16.
go back to reference Morris DH, Khunti K, Achana F et al (2013) Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56:1489–1493CrossRefPubMed Morris DH, Khunti K, Achana F et al (2013) Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56:1489–1493CrossRefPubMed
17.
go back to reference Nathan DM, Davidson MB, DeFronzo RA et al (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753–759CrossRefPubMed Nathan DM, Davidson MB, DeFronzo RA et al (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753–759CrossRefPubMed
18.
go back to reference Menke A, Rust KF, Fradkin J et al (2014) Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med 161:328CrossRefPubMed Menke A, Rust KF, Fradkin J et al (2014) Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med 161:328CrossRefPubMed
19.
go back to reference Delahanty LM, Pan Q, Jablonski KA et al (2014) Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program. Diabetes Care 37:2738–2745CrossRefPubMedPubMedCentral Delahanty LM, Pan Q, Jablonski KA et al (2014) Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program. Diabetes Care 37:2738–2745CrossRefPubMedPubMedCentral
20.
go back to reference Gannon B, DiPietro L, Poehlman ET (2000) Do African Americans have lower energy expenditure than Caucasians? J Int Assoc Study Obes 24:4–13CrossRef Gannon B, DiPietro L, Poehlman ET (2000) Do African Americans have lower energy expenditure than Caucasians? J Int Assoc Study Obes 24:4–13CrossRef
21.
go back to reference Wei GS, Coady SA, Goff DC et al (2011) Blood pressure and the risk of developing diabetes in African Americans and whites: ARIC, CARDIA, and the Framingham Heart Study. Diabetes Care 34:873–879CrossRefPubMedPubMedCentral Wei GS, Coady SA, Goff DC et al (2011) Blood pressure and the risk of developing diabetes in African Americans and whites: ARIC, CARDIA, and the Framingham Heart Study. Diabetes Care 34:873–879CrossRefPubMedPubMedCentral
22.
go back to reference Saad MF, Lillioja S, Nyomba BL et al (1991) Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733–739CrossRefPubMed Saad MF, Lillioja S, Nyomba BL et al (1991) Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733–739CrossRefPubMed
23.
go back to reference Das UN (2008) Risk of type 2 diabetes mellitus in those with hypertension. Eur Heart J 29:952–953CrossRefPubMed Das UN (2008) Risk of type 2 diabetes mellitus in those with hypertension. Eur Heart J 29:952–953CrossRefPubMed
24.
go back to reference Jeon CY, Lokken RP, Hu FB, van Dam RM (2007) Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care 30:744–752CrossRefPubMed Jeon CY, Lokken RP, Hu FB, van Dam RM (2007) Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care 30:744–752CrossRefPubMed
25.
go back to reference Crespo CJ, Smit E, Andersen RE et al (2000) Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Prev Med 18:46–53CrossRefPubMed Crespo CJ, Smit E, Andersen RE et al (2000) Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Prev Med 18:46–53CrossRefPubMed
26.
go back to reference Krishnan S, Rosenberg L, Palmer JR (2008) Physical activity and television watching in relation to risk of type 2 diabetes: the Black Women’s Health Study. Am J Epidemiol 169:428–434CrossRefPubMedPubMedCentral Krishnan S, Rosenberg L, Palmer JR (2008) Physical activity and television watching in relation to risk of type 2 diabetes: the Black Women’s Health Study. Am J Epidemiol 169:428–434CrossRefPubMedPubMedCentral
27.
go back to reference Willi C, Bodenmann P, Ghali WA et al (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298:2654–2664CrossRefPubMed Willi C, Bodenmann P, Ghali WA et al (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298:2654–2664CrossRefPubMed
28.
go back to reference Frati AC, Iniestra F, Ariza CR (1996) Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 19:112–118CrossRefPubMed Frati AC, Iniestra F, Ariza CR (1996) Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 19:112–118CrossRefPubMed
29.
go back to reference Piatti P, Setola E, Galluccio E et al (2014) Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome. Acta Diabetol 51:793–799CrossRefPubMed Piatti P, Setola E, Galluccio E et al (2014) Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome. Acta Diabetol 51:793–799CrossRefPubMed
30.
go back to reference Janzon L, Berntorp K, Hanson M et al (1983) Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia 25:86–88CrossRefPubMed Janzon L, Berntorp K, Hanson M et al (1983) Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia 25:86–88CrossRefPubMed
31.
go back to reference Wareham NJ, Ness EM, Byrne CD et al (1996) Cigarette smoking is not associated with hyperinsulinemia: evidence against a causal relationship between smoking and insulin resistance. Metabolism 45:1551–1556CrossRefPubMed Wareham NJ, Ness EM, Byrne CD et al (1996) Cigarette smoking is not associated with hyperinsulinemia: evidence against a causal relationship between smoking and insulin resistance. Metabolism 45:1551–1556CrossRefPubMed
32.
go back to reference Lycett D, Nichols L, Ryan R et al (2015) The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. Lancet Diabetes Endocrinol 3:423–430CrossRefPubMed Lycett D, Nichols L, Ryan R et al (2015) The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. Lancet Diabetes Endocrinol 3:423–430CrossRefPubMed
33.
go back to reference Yeh H-C, Duncan BB, Schmidt MI et al (2010) Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med 152:10–17CrossRefPubMed Yeh H-C, Duncan BB, Schmidt MI et al (2010) Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med 152:10–17CrossRefPubMed
34.
go back to reference Liese AD, Nichols M, Sun X et al (2009) Adherence to the DASH diet is inversely associated with incidence of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes Care 32:1434–1436CrossRefPubMedPubMedCentral Liese AD, Nichols M, Sun X et al (2009) Adherence to the DASH diet is inversely associated with incidence of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes Care 32:1434–1436CrossRefPubMedPubMedCentral
35.
go back to reference Shirani F, Salehi-Abargouei A, Azadbakht L (2013) Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials. Nutrition 29:939–947CrossRefPubMed Shirani F, Salehi-Abargouei A, Azadbakht L (2013) Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials. Nutrition 29:939–947CrossRefPubMed
36.
go back to reference Martinez-Gonzalez MA, de la Fuente-Arrillaga C, Nunez-Cordoba JM et al (2008) Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ 336:1348–1351CrossRefPubMedPubMedCentral Martinez-Gonzalez MA, de la Fuente-Arrillaga C, Nunez-Cordoba JM et al (2008) Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ 336:1348–1351CrossRefPubMedPubMedCentral
37.
go back to reference Salas-Salvado J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19CrossRefPubMed Salas-Salvado J, Bullo M, Babio N et al (2011) Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 34:14–19CrossRefPubMed
38.
go back to reference Schwingshackl L, Missbach B, König J, Hoffmann G (2015) Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr 18:1292–1299CrossRefPubMed Schwingshackl L, Missbach B, König J, Hoffmann G (2015) Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr 18:1292–1299CrossRefPubMed
39.
go back to reference Esposito K, Kastorini C-M, Panagiotakos DB, Giugliano D (2010) Prevention of type 2 diabetes by dietary patterns: a systematic review of prospective studies and meta-analysis. Metab Syndr Relat Disord 8:471–476CrossRefPubMed Esposito K, Kastorini C-M, Panagiotakos DB, Giugliano D (2010) Prevention of type 2 diabetes by dietary patterns: a systematic review of prospective studies and meta-analysis. Metab Syndr Relat Disord 8:471–476CrossRefPubMed
40.
go back to reference Soedamah-Muthu SS, Ding EL, Al-Delaimy WK et al (2011) Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr 93:158–171CrossRefPubMed Soedamah-Muthu SS, Ding EL, Al-Delaimy WK et al (2011) Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr 93:158–171CrossRefPubMed
41.
go back to reference O’Connor LM, Lentjes MAH, Luben RN et al (2014) Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 57:909–917CrossRefPubMedPubMedCentral O’Connor LM, Lentjes MAH, Luben RN et al (2014) Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 57:909–917CrossRefPubMedPubMedCentral
42.
go back to reference Yakoob MY, Shi P, Willett WC et al (2016) Circulating biomarkers of dairy fat and risk of incident diabetes mellitus among men and women in the United States in two large prospective cohorts. Circulation 133:1645–1654CrossRefPubMed Yakoob MY, Shi P, Willett WC et al (2016) Circulating biomarkers of dairy fat and risk of incident diabetes mellitus among men and women in the United States in two large prospective cohorts. Circulation 133:1645–1654CrossRefPubMed
43.
go back to reference Villegas R, Liu S, Gao Y-T et al (2007) Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med 167:2310–2316CrossRefPubMed Villegas R, Liu S, Gao Y-T et al (2007) Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med 167:2310–2316CrossRefPubMed
44.
go back to reference Sluijs I, van der Schouw YT, van der A DL et al (2010) Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands (EPIC-NL) study. Am J Clin Nutr 92:905–911 Sluijs I, van der Schouw YT, van der A DL et al (2010) Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands (EPIC-NL) study. Am J Clin Nutr 92:905–911
45.
go back to reference Burger KNJ, Beulens JWJ, Boer JMA et al (2011) Dietary glycemic load and glycemic index and risk of coronary heart disease and stroke in Dutch men and women: the EPIC-MORGEN study. PLoS ONE 6, e25955CrossRefPubMedPubMedCentral Burger KNJ, Beulens JWJ, Boer JMA et al (2011) Dietary glycemic load and glycemic index and risk of coronary heart disease and stroke in Dutch men and women: the EPIC-MORGEN study. PLoS ONE 6, e25955CrossRefPubMedPubMedCentral
46.
go back to reference Pankow JS, Duncan BB, Schmidt MI et al (2004) Fasting plasma free fatty acids and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care 27:77–82CrossRefPubMed Pankow JS, Duncan BB, Schmidt MI et al (2004) Fasting plasma free fatty acids and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care 27:77–82CrossRefPubMed
Metadata
Title
The association of ideal cardiovascular health with incident type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis
Authors
Joshua J. Joseph
Justin B. Echouffo-Tcheugui
Mercedes R. Carnethon
Alain G. Bertoni
Christina M. Shay
Haitham M. Ahmed
Roger S. Blumenthal
Mary Cushman
Sherita H. Golden
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4003-7

Other articles of this Issue 9/2016

Diabetologia 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.